Literature DB >> 21180640

Psychopathology in multiple sclerosis: diagnosis, prevalence and treatment.

Ida S Haussleiter1, Martin Brüne, Georg Juckel.   

Abstract

Multiple sclerosis (MS) is a chronic inflammatory disorder of the central nervous system. Demyelinization of nerve fibres not only affects the motor and sensory systems functionally, but may also cause psychopathological signs and symptoms. In addition to the psychiatric manifestations of MS, many patients have reactive psychological problems that are often hard to distinguish from the 'organic' causation of psychopathology. In any event, psychiatric comorbidity in MS deserves greater clinical attention than has been previously paid, because the presence of psychopathology may have deleterious effects on the disease process and impair coping with disability.

Entities:  

Keywords:  coping; multiple sclerosis; outcome; psychiatric comorbidity

Year:  2009        PMID: 21180640      PMCID: PMC3002616          DOI: 10.1177/1756285608100325

Source DB:  PubMed          Journal:  Ther Adv Neurol Disord        ISSN: 1756-2856            Impact factor:   6.570


  129 in total

1.  Treating fatigue in patients with MS: one step forward, one step back.

Authors:  Steven R Schwid; T Jock Murray
Journal:  Neurology       Date:  2005-04-12       Impact factor: 9.910

2.  Defining and diagnosing involuntary emotional expression disorder.

Authors:  Jeffrey L Cummings; David B Arciniegas; Benjamin R Brooks; Robert M Herndon; Edward C Lauterbach; Erik P Pioro; Robert G Robinson; Douglas W Scharre; Randolph B Schiffer; Daniel Weintraub
Journal:  CNS Spectr       Date:  2006-06       Impact factor: 3.790

3.  Suicide and multiple sclerosis: an epidemiological investigation.

Authors:  E N Stenager; E Stenager; N Koch-Henriksen; H Brønnum-Hansen; K Hyllested; K Jensen; U Bille-Brahe
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-07       Impact factor: 10.154

Review 4.  Evidenced-based cognitive rehabilitation for persons with multiple sclerosis: a review of the literature.

Authors:  Amanda R O'Brien; Nancy Chiaravalloti; Yael Goverover; John Deluca
Journal:  Arch Phys Med Rehabil       Date:  2008-04       Impact factor: 3.966

5.  Depressive symptoms and severity of illness in multiple sclerosis: epidemiologic study of a large community sample.

Authors:  Lydia Chwastiak; Dawn M Ehde; Laura E Gibbons; Mark Sullivan; James D Bowen; George H Kraft
Journal:  Am J Psychiatry       Date:  2002-11       Impact factor: 18.112

6.  Classification criteria for mild cognitive impairment: a population-based validation study.

Authors:  K Ritchie; S Artero; J Touchon
Journal:  Neurology       Date:  2001-01-09       Impact factor: 9.910

7.  An examination of suicidal intent in patients with multiple sclerosis.

Authors:  Anthony Feinstein
Journal:  Neurology       Date:  2002-09-10       Impact factor: 9.910

8.  Symptomatic fatigue in multiple sclerosis.

Authors:  J E Freal; G H Kraft; J K Coryell
Journal:  Arch Phys Med Rehabil       Date:  1984-03       Impact factor: 3.966

9.  The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R).

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Doreen Koretz; Kathleen R Merikangas; A John Rush; Ellen E Walters; Philip S Wang
Journal:  JAMA       Date:  2003-06-18       Impact factor: 56.272

10.  Dementia 2: early diagnosis and initial nursing care.

Authors:  Bethany Shackleton; Karen Harrison; Clare Taylor
Journal:  Nurs Times       Date:  2008 Feb 19-25
View more
  28 in total

1.  Ages of Onset of Mood and Anxiety Disorders in Fragile X Premutation Carriers.

Authors:  Andreea L Seritan; James A Bourgeois; Andrea Schneider; Yi Mu; Randi J Hagerman; Danh V Nguyen
Journal:  Curr Psychiatry Rev       Date:  2013-02

2.  Temporal lobe lesions and psychosis in multiple sclerosis.

Authors:  R Yadav; A S Zigmond
Journal:  BMJ Case Rep       Date:  2010-10-12

Review 3.  The manifestation of affective symptoms in multiple sclerosis and discussion of the currently available diagnostic assessment tools.

Authors:  Melanie Filser; Axel Buchner; Gereon Rudolf Fink; Stefan M Gold; Iris-Katharina Penner
Journal:  J Neurol       Date:  2022-09-21       Impact factor: 6.682

4.  Mood disorder as the presenting manifestation of demyelination.

Authors:  D Tapos; L Sivaswamy
Journal:  Case Rep Neurol       Date:  2013-05-03

Review 5.  Microbiome, inflammation, epigenetic alterations, and mental diseases.

Authors:  Reza Alam; Hamid M Abdolmaleky; Jin-Rong Zhou
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2017-07-10       Impact factor: 3.358

6.  Exploring the role of microglia in mood disorders associated with experimental multiple sclerosis.

Authors:  Antonietta Gentile; Francesca De Vito; Diego Fresegna; Alessandra Musella; Fabio Buttari; Silvia Bullitta; Georgia Mandolesi; Diego Centonze
Journal:  Front Cell Neurosci       Date:  2015-06-25       Impact factor: 5.505

7.  Can meditation influence quality of life, depression, and disease outcome in multiple sclerosis? Findings from a large international web-based study.

Authors:  Adam B Levin; Emily J Hadgkiss; Tracey J Weiland; Claudia H Marck; Dania M van der Meer; Naresh G Pereira; George A Jelinek
Journal:  Behav Neurol       Date:  2014-11-12       Impact factor: 3.342

8.  Research-to-Practice Gaps in Multiple Sclerosis Care for Patients with Subjective Cognitive, Mental Health, and Psychosocial Concerns in a Canadian Center.

Authors:  Lisa A S Walker; Courtney Gardner; Mark S Freedman; Heather MacLean; Carolina Rush; Marjorie Bowman
Journal:  Int J MS Care       Date:  2019 Nov-Dec

Review 9.  The Non-Obese Diabetic Mouse Strain as a Model to Study CD8(+) T Cell Function in Relapsing and Progressive Multiple Sclerosis.

Authors:  Prenitha Mercy Ignatius Arokia Doss; Andrée-Pascale Roy; AiLi Wang; Ana Carrizosa Anderson; Manu Rangachari
Journal:  Front Immunol       Date:  2015-10-22       Impact factor: 7.561

10.  The relation between Vitamin D status with fatigue and depressive symptoms of multiple sclerosis.

Authors:  Fereshteh Ashtari; Masoomeh Ajalli; Vahid Shaygannejad; Mojtaba Akbari; Silva Hovsepian
Journal:  J Res Med Sci       Date:  2013-03       Impact factor: 1.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.